GC06 GC06 Nuevas terapias en cáncer

Guil-Luna S, Rivas-Crespo A, Navarrete-Sirvent C, Mantrana A, Pera A, Mena-Osuna R, Toledano-Fonseca M, García-Ortíza MV, Villar C, Sanchez-Montero MT, Krueger J, Medina-Fernandez FJ, Haba-Rodríguez JDL, Auxiliadora E, Aranda E, Rudd CE, Rodríguez-Ariza A

Clinical significance of glycogen synthase kinase 3 (GSK-3) expression and tumor budding grade in colorectal cancer: Implications for targeted therapy

BIOMEDICINE & PHARMACOTHERAPY

DOI: 10.1016/j.biopha.2023.115592

Arjona-Sánchez A, Espinosa-Redondo E, Gutiérrez-Calvo A, Segura-Sampedro JJ, Pérez-Viejo E, Concepción-Martín V, Sánchez-García S, García-Fadrique A, Prieto-Nieto I, Barrios-Sanchez P, Torres-Melero J, Faraco MR, Prada-Villaverde A, Carrasco-Campos J, Artiles-Armas M, Villarejo-Campos P, Ortega-Pérez G, Boldo-Roda E, Sánchez-Hidalgo JM, Casado-Adam A, Rodríguez-Ortiz L, Aranda E, Cano-Osuna MT, Díaz-López C, Romero-Ruiz A, Briceño-Delgado J, Rufián-Peña S

Efficacy and Safety of Intraoperative Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Colon Cancer A Phase 3 Randomized Clinical Trial

JAMA SURGERY

DOI: 10.1001/jamasurg.2023.0662

Garcia-Torres F, Garcia-Carmona M, Rubio S, Luque B, Gomez-Solis A, Aranda E

Feasibility study of a mobile application (ACT-ON) to complement acceptance and commitment therapy (ACT) intervention in cancer patients

INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS

DOI: 10.1016/j.ijmedinf.2023.105131

Salguero J, Chamorro L, Gómez-Gómez E, de Benito P, Robles JE, Campos JP

Kidney Survival Impact of Delayed Graft Function Depends on Kidney Donor Risk Index: A Single-Center Cohort Study

JOURNAL OF CLINICAL MEDICINE

DOI: 10.3390/jcm12196397

Mena-Osuna R, Mantrana A, Guil-Luna S, Sanchez-Montero MT, Navarrete-Sirvent C, Morales-Ruiz T, Rivas-Crespo A, Toledano-Fonseca M, Garcia-Ortiz MV, Garcia-Jurado G, Gomez-Espana MA, Gonzalez-Fernandez R, Villar C, Medina-Fernandez FJ, Villalba JM, Aranda E, Rodriguez-Ariza A

Metabolic shift underlies tumor progression and immune evasion in S-nitrosoglutathione reductase-deficient cancer

JOURNAL OF PATHOLOGY

DOI: 10.1002/path.6080

Salguero J, Chamorro L, Gomez-Gomez E, Robles JE, Campos JP

Midterm Outcomes of Kidney Transplantation from Expanded Criteria Donors After Circulatory Death: A Single-Center Retrospective Cohort Study

EXPERIMENTAL AND CLINICAL TRANSPLANTATION

DOI: 10.6002/ect.2023.0076

Grávalos C, Pereira F, Vera R, Arjona-Sánchez A, Losa F, Ramos I, García-Alfonso P, Gonzalez-Bayón L, Cascales-Campos PA, Aranda E

Recommendations for the optimal management of peritoneal metastases in patients with colorectal cancer: a TTD and GECOP-SEOQ expert consensus statement

CLINICAL & TRANSLATIONAL ONCOLOGY

DOI: 10.1007/s12094-023-03204-7

Pedraza-Arevalo S, Alors-Perez E, Blazquez-Encinas R, Herrera-Martinez AD, Jimenz-Vacas JM, Fuentes-Fayos AC, Reyes O, Ventura S, Sanchez-Sanchez R, Ortega-Salas R, Serrano-Blanch R, Galvez-Moreno MA, Gahete MD, Ibanez-Costa A, Luque RM, Castano JP

Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors

TRANSLATIONAL RESEARCH

DOI: 10.1016/j.trsl.2022.07.005

Herrera-Martinez AD, Idougourram SL, Jimenez CM, Rodriguez-Alonso R, Echague RA, Palomino SC, Sanz AS, Garcia GM, Moreno MAG, Continente AC, Puertas MJM

Standard Hypercaloric, Hyperproteic vs

Leucine-Enriched Oral Supplements in Patients with Cancer-Induced Sarcopenia, a Randomized Clinical Trial

DOI: 10.3390/nu15122726

Castillo LC, Morales LG, Lopez DR, Segura JS, Rosa JV, Curado FJA, Quesada JM, Pedregosa AB, Valiente JC, Gomez EG

The role of multiparametric magnetic resonance in active surveillance of a low-risk prostate cancer cohort from clinical practice

PROSTATE

DOI: 10.1002/pros.24515

Fernandez-Perez MP, Perez-Navarro E, Alonso-Gordoa T, Conteduca V, Font A, Vazquez-Estevez S, Gonzalez-del-Alba A, Wetterskog D, Antonarakis ES, Mellado B, Fernandez-Calvo O, Mendez-Vidal MJ, Climent MA, Duran I, Gallardo E, Sanchez AR, Santander C, Saez MI, Puente J, Tudela J, Martinez A, Lopez-Andreo MJ, Padilla J, Lozano R, Hervas D, Luo J, de Giorgi U, Castellano D, Attard G, Grande E, Gonzalez-Billalabeitia E

A correlative biomarker study and integrative prognostic model in chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide

PROSTATE

DOI: 10.1002/pros.24469

Filella X, González A, Augé JM, Barco A, Carbonell R, Gaspar MJ, Martínez-Peinado A, Barrios CP, Sánchez-Carbayo M, Santotoribio JD, Trapé J

A new approach to prostate cancer screening

ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO

DOI: 10.1515/almed-2023-0082

Toledano-Fonseca M, Gomez-Espana MA, Elez E, Gravalos C, Garcia-Alfonso P, Rodriguez R, Losa F, Diaz IA, Grana B, Valladares-Ayerbes M, Garcia-Ortiz MV, Polo E, Salgado M, Rivera F, Safont MJ, Salud A, Ruiz-Casado A, Tabernero JM, Riesco MC, Rodriguez-Ariza A, Aranda E

A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients

BIOMEDICINE & PHARMACOTHERAPY

DOI: 10.1016/j.biopha.2023.114272

Guil-Luna S, Sanchez-Cespedes R, Crespo AR, Fernandez MD, Sarmiento JAF, Rodriguez-Ariza A, Millan Y

Analysis of cell-free DNA concentration, fragmentation patterns and TP53 gene expression in mammary tumor-bearing dogs: A pilot study

FRONTIERS IN VETERINARY SCIENCE

DOI: 10.3389/fvets.2023.1157878

Jimenez-Fonseca P, Sastre J, Garcia-Alfonso P, Gomez-Espana MA, Salud A, Gil S, Rivera F, Reina JJ, Quintero G, Valladares-Ayerbes M, Safont MJ, La Casta A, Robles-Diaz L, Garcia-Paredes B, Lopez RL, Guillot M, Gallego J, Alonso-Orduna V, Diaz-Rubio E, Aranda E

Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNu-1 and Phase II VISNu-2 Randomized Trials

CLINICAL COLORECTAL CANCER

DOI: 10.1016/j.clcc.2023.02.004

Calleja MA, Albanell J, Aranda E, Garcia-Foncillas J, Feliu A, Rivera F, Oyaguez I, Salinas-Ortega L, Alvarez JS

Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain

EUROPEAN JOURNAL OF HOSPITAL PHARMACY

DOI: 10.1136/ejhpharm-2021-002955

García-Ortiz MV, Cano-Ramírez P, Toledano-Fonseca M, Cano MT, Inga-Saavedra E, Rodríguez-Alonso RM, Guil-Luna S, Gómez-España MA, Rodríguez-Ariza A, Aranda E

Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancer

CLINICAL EPIGENETICS

DOI: 10.1186/s13148-023-01535-4

Aix SP, Ciuleanu TE, Navarro A, Cousin S, Bonanno L, Smit EF, Chiappori A, Olmedo ME, Horvath I, Grohe C, Farago AF, Lopez-Vilarino JA, Cullell-Young M, Nieto A, Vasco N, Gomez J, Kahatt C, Zeaiter A, Carcereny E, Roubec J, Syrigos K, Lo G, Barneto I, Pope A, Sanchez A, Kattan J, Zarogoulidis K, Waller CF, Bischoff H, Juan-Vidal O, Reinmuth N, Domine M, Paz-Ares L

Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial

LANCET RESPIRATORY MEDICINE

DOI: 10.1016/S2213-2600(22)00309-5

García-Ortiz MV, Cano-Ramírez P, Toledano-Fonseca M, Aranda E, Rodríguez-Ariza A

Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects

BIOMARKER RESEARCH

DOI: 10.1186/s40364-023-00528-y

Bonilla CE, Montenegro P, O'Connor JM, Hernando-Requejo O, Aranda E, Llerena JP, Llontop A, Escobar JG, Romero MDD, Hernandez YB, Suarez BG, Batagelj EJ, Mushtaq AW, Garcia-Foncillas J

Ibero-American Consensus Review and Incorporation of New Biomarkers for Clinical Practice in Colorectal Cancer

CANCERS

DOI: 10.3390/cancers15174373

Choueiri TK, Eto M, Motzer R, De Giorgi U, Buchler T, Basappa NS, Mendez-Vidal MJ, Tjulandin S, Park SH, Melichar B, Hutson T, Alemany C, McGregor B, Powles T, Grunwald V, Alekseev B, Rha SY, Kopyltsov E, Kapoor A, Gordoa TA, Goh JC, Staehler M, Merchan JR, Xie R, Perini RF, Mody K, McKenzie J, Porta C

Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study

LANCET ONCOLOGY

DOI: 10.1016/S1470-2045(23)00049-9

Vidal J, Fernandez-Rodriguez MC, Casadevall D, Garcia-Alfonso P, Paez D, Guix M, Alonso V, Cano MT, Santos C, Duran G, Elez E, Manzano JL, Garcia-Carbonero R, Ferreiro R, Losa F, Pineda E, Sastre J, Rivera F, Bellosillo B, Tabernero J, Aranda E, Salazar R, Montagut C

Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer: PLATFORM-B Study

CLINICAL CANCER RESEARCH

DOI: 10.1158/1078-0432.CCR-22-1696

de Velasco G, Alonso-Gordoa T, Rodriguez-Vida A, Anguera G, Campayo M, Pinto A, Ortega EM, Gallardo E, Nunez NF, Garcia-Carbonero I, Reig O, Mendez-Vidal MJ, Fernandez-Calvo O, Cassinello NV, Torregrosa D, Lopez-Martin A, Rosero A, Valiente PG, de Espana CG, Climent MA, Santasusana MD, Sanchez AR, Gonzalez IC, Afonso R, del Muro XG, Casinello J, Fernandez-Parra EM, Sanchez LG, Afonso J, Polo SH, Asensio U

Long-term Clinical Outcomes of a Spanish Cohort of Metastatic Renal Cell Carcinoma Patients with a Complete Response to Sunitinib

CLINICAL GENITOURINARY CANCER

DOI: 10.1016/j.clgc.2022.11.021

Raimondi A, Nichetti F, Stahler A, Wasan HS, Aranda E, Randon G, Kurreck A, Meade AM, Diaz-Rubio E, Niger M, Stintzing S, Palermo F, Trarbach T, Prisciandaro M, Sommerhauser G, Fisher D, Morano F, Pietrantonio F, Modest DP

Optimal maintenance strategy following FOLFOX plus anti-EGFR induction therapy in patients with RAS wild type metastatic colorectal cancer: An individual patient data pooled analysis of randomised clinical trials

EUROPEAN JOURNAL OF CANCER

DOI: 10.1016/j.ejca.2023.112945

Provencio M, Nadal E, González-Larriba JL, Martínez-Martí A, Bernabé R, Bosch-Barrera J, Casal-Rubio J, Calvo V, Insa A, Ponce S, Reguart N, de Castro J, Mosquera J, Cobo M, Aguilar A, Vivanco GL, Camps C, López-Castro R, Morán T, Barneto I, Rodríguez-Abreu D, Serna-Blasco R, Benitez R, de la Rosa CA, Palmero R, Hernando-Trancho F, Martín-López J, Cruz-Bermúdez A, Massuti B, Romero A

Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer

NEW ENGLAND JOURNAL OF MEDICINE

DOI: 10.1056/NEJMoa2215530

Arpino G, Rodriguez JD, Ferrero JM, De Placido S, Klingbiel D, Revelant V, Wohlfarth C, Poppe R, Rimawi MF, PERTAIN Study Grp

Pertuzumab, Trastuzumab, and an Aromatase Inhibitor for HER2-Positive and Hormone Receptor-Positive Metastatic or Locally Advanced Breast Cancer: PERTAIN Final Analysis

CLINICAL CANCER RESEARCH

DOI: 10.1158/1078-0432.CCR-22-1092

Grunwald V, Powles T, Eto M, Kopyltsov E, Rha SY, Porta C, Motzer R, Hutson TE, Mendez-Vidal MJ, Hong SH, Winquist E, Goh JC, Maroto P, Buchler T, Takagi T, Burgents JE, Perini R, He CX, Okpara CE, McKenzie J, Choueiri TK

Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms

FRONTIERS IN ONCOLOGY

DOI: 10.3389/fonc.2023.1223282

Suarez C, Larkin JMG, Patel P, Valderrama BP, Rodriguez-Vida A, Glen H, Thistlethwaite F, Ralph C, Srinivasan G, Mendez-Vidal MJ, Hartmaier R, Markovets A, Prendergast A, Szabados B, Mousa K, Powles T

Phase II Study Investigating the Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer (CALYPSO)

JOURNAL OF CLINICAL ONCOLOGY

DOI: 10.1200/JCO.22.01414

Fita MJJ, Herranz UA, Mendez-Vidal MJ, Girones-Sarrio R, Munoz-Langa J, Sepulveda-Sanchez J, Mellado B, Alvarez-Fernandez C, Lopez LH, Lopez-Guerrero JA, Garcia-Casado Z, Calatrava A, Climent MA

Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study

CANCERS

DOI: 10.3390/cancers15215223

Tibau A, Martinez MT, Ramos M, de la Cruz-merino L, Santaballa A, O'Connor M, Martinez-Janez N, Moreno F, Fernandez I, Virizuela JA, Alarcon J, de la Haba-rodriguez J, Sanchez-Rovira P, Albacar CR, Muino CB, Kelly C, Casas M, Bezares S, Rosell L, Albanell J

Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

DOI: 10.1177/17588359221148921

Pericay C, Montes AF, Orduña VA, Declara IM, Martínez EA, Salas NR, Torres E, Lavín DC, Alonso RMR, Falcó E, Oliva JC, Cirera L

Real-World Outcomes in Patients with Metastatic Colorectal Cancer in Spain: The RWD-ACROSS Study

CANCERS

DOI: 10.3390/cancers15184603

Mendez-Vidal MJ, Quintela ML, Lainez-Milagro N, Perez-Valderrama B, Rodriguez CS, Arija JAA, Fernandez IP, Diaz EG, Sorrosal JL, Gonzalez-del-Alba A

SEOM SOGUG clinical guideline for treatment of kidney cancer (2022)

CLINICAL & TRANSLATIONAL ONCOLOGY

DOI: 10.1007/s12094-023-03276-5

de la Pena FA, Novoa SA, Gregori JG, Cortijo LG, Carrasco FH, Martinez MTM, Estevez CM, Stradella A, Losada MJV, Ciruelos E

SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022)

CLINICAL & TRANSLATIONAL ONCOLOGY

DOI: 10.1007/s12094-023-03215-4

Montes AF, Alonso V, Aranda E, Elez E, Alfonso PG, Gravalos C, Maurel J, Vera R, Vidal R, Aparicio J

SEOM-GEMCAD-TTD clinical guidelines for the systemic treatment of metastatic colorectal cancer (2022)

CLINICAL & TRANSLATIONAL ONCOLOGY

DOI: 10.1007/s12094-023-03199-1

Guil-Luna S, Sanchez-Montero MT, Rodríguez-Ariza A

S-Nitrosylation at the intersection of metabolism and autophagy: Implications for cancer

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

DOI: 10.1016/j.bbcan.2023.189012

Montes AF, Orduña VA, Martínez EA, Salas NR, Torres E, Lavín DC, Alonso RMR, Falcó E, Oliva JC, Cirera L, Gómez JG, Pericay C

The Frequency of Specific KRAS Mutations, and Their Impact on Treatment Choice and Survival, in Patients With Metastatic Colorectal Cancer

ONCOLOGIST

DOI: 10.1093/oncolo/oyad117

Perez-Garcia JM, Batista MV, Cortez P, Ruiz-Borrego M, Cejalvo JM, de la Haba-Rodriguez J, Garrigos L, Racca F, Servitja S, Blanch S, Gion M, Nave M, Fernandez-Abad M, Martinez-Bueno A, Llombart-Cussac A, Sampayo-Cordero M, Malfettone A, Cortes J, Braga S

Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial

NEURO-ONCOLOGY

DOI: 10.1093/neuonc/noac144

Asleh K, Lluch A, Goytain A, Barrios C, Wang XQ, Torrecillas L, Gao DX, Ruiz-Borrego M, Leung S, Bines J, Guerrero-Zotano A, Garcia-Saenz JA, Cejalvo JM, Herranz J, Torres R, de la Haba-rodriguez J, Ayala F, Gomez H, Rojo F, Nielsen TO, Martin M

Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine

CLINICAL CANCER RESEARCH

DOI: 10.1158/1078-0432.CCR-22-2191

Publicaciones in 2022

Lara-Chica M, Correa-Saez A, Jimenez-Izquierdo R, Garrido-Rodriguez M, Ponce FJ, Moreno R, Morrison K, Di Vona C, Arato K, Jimenez-Jimenez C, Morrugares R, Schmitz ML, de la Luna S, de la Vega L, Calzado MA

CELL DEATH AND DIFFERENTIATION

2022

DOI: 10.1038/s41418-021-00845-5

Climent MA, Font A, Duran I, Puente J, Mendez-Vidal MJ, Saez MI, Lobera CS, Arija JAA, Gonzalez-Del-Alba A, Sanchez-Hernandez A, Fita MJJ, Esteban E, Alonso-Gordoa T, Gonzalez BM, Maroto P, Lazaro-Quintela M, Cassinello-Espinosa J, Perez-Valderrama B, Garcias C, Castellano D

EUROPEAN JOURNAL OF CANCER

2022

DOI: 10.1016/j.ejca.2022.08.002

Argiles G, Mulet N, Valladares-Ayerbes M, Vieitez JM, Gravalos C, Garcia-Alfonso P, Santos C, Tobena M, Garcia-Paredes B, Benavides M, Cano MT, Loupakis F, Rodriguez-Garrote M, Rivera F, Goldberg RM, Cremolini C, Bennouna J, Ciardiello F, Tabernero JM, Aranda E, Tabernero J

EUROPEAN JOURNAL OF CANCER

2022

DOI: 10.1016/j.ejca.2022.09.037

Garcia-Torres F, Jablonski MJ, Gomez-Solis A, Moriana JA, Jaen-Moreno M, Moreno-Diaz MJ, Aranda E

HEALTH PSYCHOLOGY REPORT

2022

DOI: 10.5114/hpr.2021.111297

Calvo-Lopez T, Paz-Cabezas M, Llovet P, Ibanez MD, Sastre J, Alonso-Orduna V, Vieitez JM, Yubero A, Vera R, Asensio-Martinez E, Garcia-Alfonso P, Aranda E, Diaz-Rubio E, Perez-Villamil B

CANCER BIOMARKERS

2022

DOI: 10.3233/CBM-210353

Ortiz-Morales MJ, Toledano-Fonseca M, Mena-Osuna R, Cano MT, Gomez-Espana A, De la Haba-Rodriguez JR, Rodriguez-Ariza A, Aranda E

CANCERS

2022

DOI: 10.3390/cancers14133054

Herrera-Martinez Y, Gonzalez MJC, Pedraza-Arevalo S, Martinez MDG, Martinez AR, Menchen AG, Molina MAB, Galvez-Moreno MA, Moreno-Vega AL, Luque RM, Herrera-Martinez AD

FRONTIERS IN ENDOCRINOLOGY

2022

DOI: 10.3389/fendo.2021.812385

Pinto A, Reig O, Iglesias C, Gallardo E, Garcia-del Muro X, Alonso T, Anguera G, Suarez C, Munoz-Langa J, Villalobos-Leon L, Rodriguez-Sanchez A, Lainez N, Martinez-Ortega E, Campayo M, Velastegui A, Rodriguez-Vida A, Villa-Guzman JC, Mendez-Vidal MJ, Rubio G, Garcia I, Capdevila L, Lambea J, Vazquez S, Fernandez O, Hernando-Polo S, Cerezo S, Santander C, Garcia-Marrero R, Zambrana F, Gonzalez-del Alba A, Lazaro-Quintela M, Castellano D, Chirivella I, Anido U, Viana A, Garcia A, Sotelo M, Arevalo MG, Garcia-Donas J, Hernandez C, Bolos MV, Llinares J, Climent MA

CLINICAL GENITOURINARY CANCER

2022

DOI: 10.1016/j.clgc.2021.09.006

Elez E, Gomez-Espana MA, Gravalos C, Garcia-Alfonso P, Ortiz-Morales MJ, Losa F, Diaz IA, Grana B, Toledano-Fonseca M, Valladares-Ayerbes M, Polo E, Salgado M, De Castro EM, Safont MJ, Salud A, Ruiz-Casado A, Tabernero J, Riesco MD, Rodriguez-Ariza A, Aranda E

BRITISH JOURNAL OF CANCER

2022

DOI: 10.1038/s41416-021-01638-w

Garcia-Torres F, Tejero-Perea A, Gomez-Solis A, Castillo-Mayen R, Jaen-Moreno MJ, Luque B, Galvez-Lara M, Sanchez-Raya A, Jablonski M, Rodriguez-Alonso B, Aranda E

TRIALS

2022

DOI: 10.1186/s13063-022-06731-w

Garcia-Torres F, Gomez-Solis A, Garcia SR, Castillo-Mayen R, Ruiz-Ruano VG, Moreno E, Moriana JA, Luque-Salas B, Jaen-Moreno MJ, Cuadrado-Hidalgo F, Galvez-Lara M, Jablonski M, Rodriguez-Alonso B, Aranda E

FRONTIERS IN PSYCHOLOGY

2022

DOI: 10.3389/fpsyg.2022.871929

Pedraza-Arevalo S, Ibanez-Costa A, Blazquez-Encinas R, Branco MR, Vazquez-Borrego MC, Herrera-Martinez AD, Venegas-Moreno E, Serrano-Blanch R, Arjona-Sanchez A, Galvez-Moreno MA, Korbonits M, Soto-Moreno A, Gahete MD, Charalambous M, Luque RM, Castano JP

MOLECULAR ONCOLOGY

2022

DOI: 10.1002/1878-0261.13107

Szabados B, Kockx M, Assaf ZJ, van Dam PJ, Rodriguez-Vida A, Duran I, Crabb SJ, van der Heijden MS, Pous AF, Gravis G, Herranz UA, Protheroe A, Ravaud A, Maillet D, Mendez MJ, Suarez C, Linch M, Prendergast A, Tyson C, Stanoeva D, Daelemans S, Rombouts M, Mariathasan S, Tea JS, Mousa K, Sharma S, Aleshin A, Banchereau R, Castellano D, Powles T

EUROPEAN UROLOGY

2022

DOI: 10.1016/j.eururo.2022.04.013

Motzer R, Porta C, Alekseev B, Rha SY, Choueiri TK, Mendez-Vidal MJ, Hong SH, Kapoor A, Goh JC, Eto M, Bennett L, Wang JY, Pan JJ, Saretsky TL, Perini RF, He CS, Mody K, Cella D

LANCET ONCOLOGY

2022

DOI: 10.1016/S1470-2045(22)00212-1

Motzer R, Porta C, Alekseev B, Rha SY, Choueiri TK, Mendez-Vidal MJ, Hong SH, Kapoor A, Goh JC, Eto M, Bennett L, Wang J, Pan JJ, Saretsky TL, Perini R, He CS, Mody K, Cella D

ONKOUROLOGIYA

2022

DOI: 10.17650/1726-9776-2022-18-2-39-57

Porta VG, Camps C, Duran MAC, Gallardo E, del Alba AG, Lazaro-Quintela M, Vidal MJM, Marin AP, Puente J, Anton-Rodriguez C, Caballero-Martinez F, Campos-Lucas FJ, Lugo I, Rogado A, Duran I

CLINICAL & TRANSLATIONAL ONCOLOGY

2022

DOI: 10.1007/s12094-021-02703-9

Gil-Guillen VF, Balsa A, Bernardez B, Llorca CVY, Marquez-Contreras E, de la Haba-Rodriguez J, Castellano JM, Gomez-Martinez J

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH

2022

DOI: 10.3390/ijerph191912036

Montes AF, Elez E, Vivancos A, Martinez N, Gonzalez P, Covela M, de la Camara J, Cousillas A, Mendez JC, Grana B, Aranda E

CLINICAL & TRANSLATIONAL ONCOLOGY

2022

DOI: 10.1007/s12094-021-02767-7

Martin M, Zielinski C, Ruiz-Borrego M, Carrasco E, Ciruelos EM, Munoz M, Bermejo B, Margeli M, Csoszi T, Anton A, Turner N, Casas MI, Morales S, Alba E, Calvo L, De La Haba-Rodriguez J, Ramos M, Murillo L, Santaballa A, Alonso-Romero JL, Sanchez-Rovira P, Corsaro M, Huang X, Thallinger C, Kahan Z, Gil-Gil M

EUROPEAN JOURNAL OF CANCER

2022

DOI: 10.1016/j.ejca.2022.03.006

Albanell J, Perez-Garcia JM, Gil-Gil M, Curigliano G, Ruiz-Borrego M, Comerma L, Gibert J, Bellet M, Bermejo B, Calvo L, de la Haba J, Espinosa E, Minisini AM, Quiroga V, Bertran AS, Mina L, Bellosillo B, Rojo F, Menendez S, Sampayo-Cordero M, Popa C, Malfettone A, Cortes J, Llombart-Cussac A

CLINICAL CANCER RESEARCH

2022

DOI: 10.1158/1078-0432.CCR-22-1281

Albanell J, Martinez MT, Ramos M, O'Connor M, de la Cruz-Merino L, Santaballa A, Martinez-Janez N, Moreno F, Fernandez I, Alarcon J, Virizuela JA, de la Haba-Rodriguez J, Sanchez-Rovira P, Gonzalez-Cortijo L, Margeli M, Sanchez-Munoz A, Anton A, Casas M, Bezares S, Rojo F

EUROPEAN JOURNAL OF CANCER

2022

DOI: 10.1016/j.ejca.2021.11.010

Grande E, Alonso-Gordoa T, Reig O, Esteban E, Castellano D, Garcia-Del-Muro X, Mendez MJ, Garcia-Donas J, Rodriguez MG, Arranz-Arija JA, Lopez-Criado P, Molina-Cerrillo J, Mellado B, Alvarez-Fernandez C, De Velasco G, Cuellar-Rivas MA, Rodriguez-Alonso RM, Rodriguez-Moreno JF, Suarez-Rodriguez C

ESMO OPEN

2022

DOI: 10.1016/j.esmoop.2022.100463

Bofill JS, Anton FM, Sanchez CAR, Calvo EG, Melia CH, Gil EMC, Vidal M, Jimenez-Rodriguez B, Merino LD, Janez NM, Vazquez RV, Salas RD, Torres AA, Lopez IMA, Gregori JG, Garcia VQ, Rubio EV, De la Haba-Rodriguez J, Gonzalez-Santiago S, Fernandez ND, Molins AB, De Ibarguen BCS, Mingorance JID, Ezquerra MB, De Casa S, Gimeno A, Martin M

BREAST

2022

DOI: 10.1016/j.breast.2022.09.006

Herrera-Martinez Y, Teomiro CA, Idougourram SL, Puertas MJM, Continente AC, Blanch RS, Castano JP, Moreno MAG, Gahete MD, Luque RM, Herrera-Martinez AD

CANCERS

2022

DOI: 10.3390/cancers14010111

Capdevila J, Gomez MA, Guillot M, Paez D, Pericay C, Safont MJ, Tarazona N, Vera R, Vidal J, Sastre J

CLINICAL & TRANSLATIONAL ONCOLOGY

2022

DOI: 10.1007/s12094-022-02816-9

de la Haba-Rodriguez J, Lloret FF, Salgado MAV, Arce MO, Gutierrez AC, Jimenez JGD, Zambrano CB, Alonso RMR, Lopez RL, Salas NR

CLINICAL & TRANSLATIONAL ONCOLOGY

2022

DOI: 10.1007/s12094-022-02817-8

Perez-de-Villar J, Arjona-Sanchez A, Rufian-Andujar B, Valenzuela-Molina F, Sanchez-Hidalgo JM, Rodriguez-Ortiz L, Casado-Adam A, Viyuela-Garcia C, Rufian-Pena S, Caro-Cuenca T, Moreno-Vega A, Briceno-Delgado J

CIRUGIA ESPANOLA

2022

DOI: 10.1016/j.ciresp.2021.05.001

Triulzi T, Bianchini G, Di Cosimo S, Pienkowski T, Im YH, Bianchi GV, Galbardi B, Dugo M, De Cecco L, Tseng LM, Liu MC, Bermejo B, Semiglazov V, Viale G, de la Haba-Rodriguez J, Oh DY, Poirier B, Valagussa P, Gianni L, Tagliabue E

MOLECULAR ONCOLOGY

2022

DOI: 10.1002/1878-0261.13141

Ciria R, Ayllon MD, Padial A, Gomez-Serrano J, Garcia-Gaitan C, Gomez-Espana A, Espejo JJ, Briceno J

ANNALS OF SURGICAL ONCOLOGY

2022

DOI: 10.1245/s10434-021-11005-x

Casarrubios M, Provencio M, Nadal E, Insa A, Garcia-Campelo MD, Lazaro-Quintela M, Domine M, Majem M, Rodriguez-Abreu D, Martinez-Marti A, Carpeno JD, Cobo M, Vivanco GL, Del Barco E, Bernabe R, Vinolas N, Aranda IB, Massuti B, Sierra-Rodero B, Martinez-Toledo C, Fernandez-Miranda I, Serna-Blanco R, Romero A, Calvo V, Cruz-Bermudez A

JOURNAL FOR IMMUNOTHERAPY OF CANCER

2022

DOI: 10.1136/jitc-2022-005320

Benavides M, Gomez-Espana A, Garcia-Alfonso P, Gonzalez CG, Vieitez JM, Rivera F, Safont MJ, Abad A, Sastre J, Valladares-Ayerbes M, Carrato A, Gonzalez-Flores E, Robles L, Salud A, Alonso-Orduna V, Montagut C, Asensio E, Diaz-Rubio E, Aranda E

EJSO

2022

DOI: 10.1016/j.ejso.2021.11.122

Garcia-Ortiz MV, De La Torre-Aguilar MJ, Morales-Ruiz T, Gomez-Fernandez A, Flores-Rojas K, Gil-Campos M, Martin-Borreguero P, Ariza RR, Roldan-Arjona T, Perez-Navero JL

Analysis of Global and Local DNA Methylation Patterns in Blood Samples of Patients With Autism Spectrum Disorder

FRONTIERS IN PEDIATRICS

DOI: 10.3389/fped.202685310

IF: 3,418 Q1 D2

Perez-Sanchez C, Barbarroja N, Pantaleao LC, Lopez-Sanchez LM, Ozanne SE, Jurado-Gamez B, Aranda E, Lopez-Pedrera C, Rodriguez-Ariza A

Clinical Utility of microRNAs in Exhaled Breath Condensate as Biomarkers for Lung Cancer

JOURNAL OF PERSONALIZED MEDICINE

DOI: 10.3390/jpm11020111

IF: 4,945 Q1 D2

Vera R, Salgado M, Safont MJ, Gallego J, Gonzalez E, Elez E, Aranda E

Controversies in the treatment of RAS wild-type metastatic colorectal cancer

CLINICAL & TRANSLATIONAL ONCOLOGY

DOI: 10.1007/s12094-020-02475-8

IF: 3,405 Q3

Garcia-Alfonso P, Munoz A, Jimenez-Castro J, Jimenez-Fonseca P, Pericay C, Longo-Munoz F, Reyna-Fortes C, Argiles-Martinez G, Gonzalez-Astorga B, Gomez-Reina MJ, Ruiz-Casado A, Rodriguez-Salas N, Lopez-Lopez R, Carmona-Bayonas A, Conde-Herrero V, Aranda E

Early Clinical Experience with Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: The ROS Study

CANCERS

DOI: 10.3390/cancers1318451

IF: 6,639 Q1 D3

Garcia-Alfonso P, Diaz-Rubio E, Abad A, Carrato A, Massuti B, Ortiz-Morales MJ, Mozo JLM, Munoz A, Duran G, Sastre J, Safont MJ, Ferreiro R, Rivera F, Gonzalez E, Valladares-Ayerbes M, Gravalos C, Alonso-Orduna V, Vieitez JM, Yubero A, Aranda E

First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis

DRUGS & AGING

DOI: 10.1007/s40266-021-00834-w

IF: 3,923 Q2 D5

Guil-Luna S, Sedlik C, Piaggio E

Humanized Mouse Models to Evaluate Cancer Immunotherapeutics

ANNUAL REVIEW OF CANCER BIOLOGY, VOL 5, 2021

DOI: 10.1146/annurev-cancerbio-050520-100526

IF: 9,391 Q1 D2

Manzanares-Martin B, Aranda AC, del Puerto-Nevado L, Gonzalez R, Solanes S, Gomez-Espana MA, Garcia-Foncillas J, Aranda E

Improving selection of patients with metastatic colorectal cancer to benefit from cetuximab based on KIR genotypes

JOURNAL FOR IMMUNOTHERAPY OF CANCER

DOI: 10.1136/jitc-2020-001705

IF: 13,751 Q1 D1

Lopez-Sanchez LM, Mena R, Guil-Luna S, Mantrana A, Penarando J, Toledano-Fonseca M, Conde F, De La Haba-Rodriguez JR, Aranda E, Rodriguez-Ariza A

Nitric oxide-targeted therapy inhibits stemness and increases the efficacy of tamoxifen in estrogen receptor-positive breast cancer cells

LABORATORY INVESTIGATION

DOI: 10.1038/s41374-020-00507-z

IF: 5,662 Q1 D2

Gomez-Espana MA, Montes AF, Garcia-Carbonero R, Mercade TM, Maurel J, Martin AM, Pazo-Cid R, Vera R, Carrato A, Feliu J

SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)

CLINICAL & TRANSLATIONAL ONCOLOGY

DOI: 10.1007/s12094-021-02573-1

IF: 3,405 Q3 D

Toledano-Fonseca M, Cano MT, Inga E, Gomez-Espana A, Guil-Luna S, Garcia-Ortiz MV, Mena-Osuna R, De la Haba-Rodriguez JR, Rodriguez-Ariza A, Aranda E

The Combination of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio with Liquid Biopsy Biomarkers Improves Prognosis Prediction in Metastatic Pancreatic Cancer

CANCERS

DOI: 3390/cancers13061210

IF: 6,639 Q1 D3

Garcia-Carmona M, Garcia-Torres F, Jablonski MJ, Solis AG, Jaen-Moreno MJ, Moriana JA, Moreno-Diaz MJ, Aranda E

The influence of family social support on quality of life of informal caregivers of cancer patients

NURSING OPEN

DOI: 10.1002/nop2.887

IF: 1,762 Q3

Alors-Perez E, Blazquez-Encinas R, Alcala S, Viyuela-Garcia C, Pedraza-Arevalo S, Herrero-Aguayo V, Jimenez-Vacas JM, Mafficini A, Sanchez-Frias ME, Cano MT, Abollo-Jimenez F, Marin-Sanz JA, Cabezas-Sainz P, Lawlor RT, Luchini C, Sanchez L, Sanchez-Hidalgo JM, Ventura S, Martin-Hijano L, Gahete MD, Scarpa A, Arjona-Sanchez A, Ibanez-Costa A, Sainz B, Luque RM, Castano JP

Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

DOI: 10.1186/s13046-021-02153-9

IF: 11,161 Q1 D1

Sastre J, Garcia-Alfonso P, Vieitez JM, Cano MT, Rivera F, Reina-Zoilo JJ, Salud-Salvia A, Quintero G, Robles-Diaz L, Safont MJ, La Casta A, Gil S, Polo E, Asensio-Martinez E, Garcia-Paredes B, Lopez RL, Guillot M, Valladares-Ayerbes M, Aranda E, Diaz-Rubio E

Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and < 3 baseline circulating tumour cells: the randomised phase II VISNU-2 study

ESMO OPEN

DOI: 10.1016/j.esmoop.2021.10006

IF: 6,54 Q1 D3

Conde E, Earl J, Crespo-Toro L, Blanco-Agudo C, Ramos-Munoz E, Rodriguez-Serrano EM, Avila JCM, Salinas-Munoz L, Serrano-Huertas S, Ferreiro R, Rodriguez-Garrote M, Sainz B, Massuti B, Alfonso PG, Benavides M, Aranda E, Garcia-Bermejo ML, Carrato A

Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular Study

CANCERS

DOI: 10.3390/cancers13071710

IF: 6,639 Q1 D3

Sierra-Rodero B, Cruz-Bermudez A, Nadal E, Garitaonaindia Y, Insa A, Mosquera J, Casal-Rubio J, Domine M, Majem M, Rodriguez-Abreu D, Martinez-Marti A, Carpeno JD, Cobo M, Vivanco GL, Del Barco E, Caro RB, Vinolas N, Aranda IB, Viteri S, Massuti B, Laza-Briviesca R, Casarrubios M, Garcia-Grande A, Romero A, Franco F, Provencio M

Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial

JOURNAL FOR IMMUNOTHERAPY OF CANCER

DOI: 10.1136/jitc-2021-00280

IF: 13,751 Q1 D1

Taieb J, Aranda E, Raouf S, Dunn H, Arnold D

Clinical and Regulatory Considerations for the Use of Bevacizumab Biosimilars in Metastatic Colorectal Cancer

CLINICAL COLORECTAL CANCER

DOI: 10.1016/j.clcc.2020.10.00

IF: 4,481 Q2 D5

Peters S, Danson S, Ejedepang D, Dafni U, Hasan B, Radcliffe HS, Bustin F, Crequit J, Coate L, Guillot M, Surmont V, Rauch D, Rudzki J, O'Mahony D, Aranda IB, Scherz A, Tsourti Z, Roschitzki-Voser H, Pochesci A, Demonty G, Stahel RA, O'Brien M

Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC - The ETOP/EORTC SPLENDOUR and AMGEN-249 trials

LUNG CANCER

DOI: 10.1016/j.lungcan.2021.09.002

IF: 5,705 Q1 D3

Dols MC, Zambrano CB, Gutierrez LC, Sett RC, Lopez-Barajas MIB, Navalon FG, Perez JLF, Bermudez GS, Torres PT, Mingorance ID, Marin AG, Oriol AL, Lario AP, Maurino PS, Gomez OH, Munoz DM, Lopez AJJ, Gonzalez IH, Yague AS, Lopez BS

Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis

BMJ SUPPORTIVE & PALLIATIVE CARE

DOI: 10.1136/bmjspcare-2020-002249

IF: 3,568 Q2 D4

Ribelles N, Alvarez-Lopez I, Arcusa A, Chacon JI, de la Haba J, Garcia-Corbacho J, Garcia-Mata J, Jara C, Jerez JM, Lazaro-Quintela M, Leon-Mateos L, Ramirez-Merino N, Tibau A, Garcia-Palomo A

Electronic health records and patient registries in medical oncology departments in Spain

CLINICAL & TRANSLATIONAL ONCOLOGY

DOI: 10.1007/s12094-021-02614-9

IF: 3,405 Q3 D

Motzer R, Alekseev B, Rha SY, Porta C, Eto M, Powles T, Grunwald V, Hutson TE, Kopyltsov E, Mendez-Vidal MJ, Kozlov V, Alyasova A, Hong SH, Kapoor A, Gordoa TA, Merchan JR, Winquist E, Maroto P, Goh JC, Kim M, Gurney H, Patel V, Peer A, Procopio G, Takagi T, Melichar B, Rolland F, De Giorgi U, Wong S, Bedke J, Schmidinger M, Dutcus CE, Smith AD, Dutta L, Mody K, Perini RF, Xing DY, Choueiri TK

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

NEW ENGLAND JOURNAL OF MEDICINE

DOI: 10.1056/NEJMoa2035716

Kahan Z, Gil-Gil M, Ruiz-Borrego M, Carrasco E, Ciruelos E, Munoz M, Bermejo B, Margeli M, Anton A, Casas M, Csoszi T, Murillo L, Morales S, Calvo L, Lang I, Alba E, de la Haba-Rodriguez J, Ramos M, Lopez IA, Gal-Yam E, Garcia-Palomo A, Alvarez E, Gonzalez-Santiago S, Rodriguez CA, Servitja S, Corsaro M, Rodrigalvarez G, Zielinski C, Martin M

Original Research Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive metastatic breast cancer: Patient-reported outcomes in the PEARL study

EUROPEAN JOURNAL OF CANCER

DOI: 1016/j.ejca.2021.07.004

IF: 9,192 Q1 D2

Martin M, Zielinski C, Ruiz-Borrego M, Carrasco E, Turner N, Ciruelos EM, Munoz M, Bermejo B, Margeli M, Anton A, Kahan Z, Csoszi T, Casas MI, Murillo L, Morales S, Alba E, Gal-Yam E, Guerrero-Zotano A, Calvo L, de la Haba-Rodriguez J, Ramos M, Alvarez I, Garcia-Palomo A, Bartlett CH, Koehler M, Caballero R, Corsaro M, Huang X, Garcia-Saenz JA, Chacon JI, Swift C, Thallinger C, Gil-Gil M

Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARL

ANNALS OF ONCOLOGY

DOI: 10.1016/j.annonc.2020.12.013

IF: 32,976 Q1 D1

Astorga BG, Ballabrera FS, Aguilar EA, Fernandez EE, Garcia-Alfonso P, Flores EG, Garcia RV, Montes AF, Munoz AML, Salvia AS

Patient profiles as an aim to optimize selection in the second line setting: the role of aflibercept

CLINICAL & TRANSLATIONAL ONCOLOGY

DOI: 10.1007/s12094-021-02568-y

IF: 3,405 Q3

Rivera F, Izquierdo-Manuel M, Garcia-Alfonso P, de Castro EM, Gallego J, Limon ML, Alsina M, Lopez L, Galan M, Falco E, Manzano JL, Gonzalez E, Munoz-Unceta N, Lopez C, Aranda E, Fernandez E, Jorge M, Jimenez-Fonseca P

Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma: NEOHX phase II trial

EUROPEAN JOURNAL OF CANCER

DOI: 10.1016/j.ejca.2020.12.005

IF: 9,162 Q1 D2

Casarrubios M, Cruz-Bermudez A, Nadal E, Insa A, Campelo MDG, Lazaro M, Domine M, Majem M, Rodriguez-Abreu D, Martinez-Marti A, de Castro-Carpeno J, Cobo M, Lopez-Vivanco G, Del Barco E, Caro RB, Vinolas N, Aranda IB, Viteri S, Massuti B, Barquin M, Laza-Briviesca R, Sierra-Rodero B, Parra ER, Sanchez-Espiridion B, Rocha P, Kadara H, Wistuba II, Romero A, Calvo V, Provencio M

Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy

CLINICAL CANCER RESEARCH

DOI: 10.1158/1078-0432.CCR-21-1200

IF: 12,531 Q1 D1

Sartore-Bianchi A, Garcia-Alfonso P, Geissler M, Kohne CH, Peeters M, Price T, Valladares-Ayerbes M, Zhang Y, Burdon P, Taieb J, Modest DP

Relationships Between Kohne Category/Baseline Tumor Load and Early Tumor Shrinkage, Depth of Response, and Outcomes in Metastatic Colorectal Cancer

CLINICAL COLORECTAL CANCER

DOI: 10.1016/j.clcc.2021.05.007

IF: 4,481 Q2 D5

Ferre AD, Alvarez RA, Herraez AC, Jurado JC, Gonzalez AE, Martin-Broto J, Marin VM, Vega AM, Garcia AS, Morales CV

SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)

CLINICAL & TRANSLATIONAL ONCOLOGY

DOI: 10.1007/s12094-020-02534-0

IF: 3,405 Q3

del Alba AG, Mendez-Vidal MJ, Vazquez S, Castro E, Climent MA, Gallardo E, Gonzalez-Billalabeitia E, Lorente D, Maroto JP, Arranz JA

SEOM clinical guidelines for the treatment of advanced prostate cancer (2020)

CLINICAL & TRANSLATIONAL ONCOLOGY

DOI: 10.1007/s12094-021-02561-5

IF: 3,405 Q3

Gil-Gil M, Alba E, Gavila J, de la Haba-Rodriguez J, Ciruelos E, Tolosa P, Candini D, Llombart-Cussac A

The role of CDK4/6 inhibitors in early breast cancer

BREAST

DOI: 10.1016/j.breast.2021.05.008

IF: 4,38 Q1 D2

Szabados B, Rodriguez-Vida A, Duran I, Crabb SJ, Van der Heijden MS, Pous AF, Gravis G, Herranz UA, Protheroe A, Ravaud A, Maillet D, Mendez-Vidal MJ, Suarez C, Linch M, Prendergast A, Tyson C, Mousa K, Castellano D, Powles T

Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS Trial

EUROPEAN UROLOGY ONCOLOGY

DOI: 10.1016/j.euo.2020.11.010

IF: 7,479 Q1 D1

Ruedas-Torres I, Rodriguez-Gomez IM, Sanchez-Carvajal JM, Guil-Luna S, Larenas-Munoz F, Pallares FJ, Carrasco L, Gomez-Laguna J

Up-Regulation of Immune Checkpoints in the Thymus of PRRSV-1-Infected Piglets in a Virulence-Dependent Fashion

FRONTIERS IN IMMUNOLOGY

DOI: 10.3389/fimmu.2021.671743

Camps C, López R, Antón A, Aranda E, Carrato A, Cruz JJ, Cunquero-Tomás AJ, Díaz-Rubio E, Feyjóo M, García-Foncillas J, Gascón P, Lugo I, Rogado Á, Guillem V

Implementation of the Quality Oncology Practice Initiative Program in Spain: First Results and Implications

JCO Oncol Pract

DOI: 10.1200/OP.20.00683

IF: 3,487 Q3

Redondo A, Guerra E, Manso L, Martin-Lorente C, Martinez-Garcia J, Perez-Fidalgo JA, Varela MQ, Rubio MJ, Barretina-Ginesta MP, Gonzalez-Martin A

SEOM clinical guideline in ovarian cancer (2020)

Clin Transl Oncol

2021 May;23(5):961-968

DOI: 10.1007/s12094-020-02545-x

FI: 2,737 Q3

Andres Redondo, Ana Oaknin, Maria Jesus Rubio, Maria-Pilar Barretina-Ginesta, Ana de Juan, Luis Manso, Ignacio Romero, Cristina Martin-Lorente, Andres Poveda, Antonio Gonzalez-Martin

Management of advanced ovarian cancer in Spain: an expert Delphi consensus

J Ovarian Res

DOI: 10.1186/s13048-021-00816-x

FI: 6,923 Q1

J

A

Perez-Fidalgo, A

DOI: 10.1016/j.esmoop.2021.100212

FI: 5,329 Q1

Guil-Luna S, Mena R, Navarrete-Sirvent C, Lopez-Sanchez LM, Khouadri K, Toledano-Fonseca M, Mantrana A, Guler I, Villar C, Diaz C, Medina-Fernandez FJ, De la Haba-Rodriguez JR, Aranda E, Rodriguez-Ariza A,

Association of Tumor Budding With Immune Evasion Pathways in Primary Colorectal Cancer and Patient-Derived Xenografts

FRONTIERS IN MEDICINE

DOI: 10.3389/fmed.2020.00264

IF: 3,9 Q: 1

Gavila J, De La Haba J, Bermejo B, Rodriguez-Lescure A, Anton A, Ciruelos E, Brunet J, Munoz-Couselo E, Santisteban M, Sanchez CAR, Santaballa A, Rovira PS, Saenz JAG, Ruiz-Borrego M, Guerrero-Zotano AL, Huerta M, Cotes-Sanches A, Romera JL, Aguirre E, Co

A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study

CLINICAL & TRANSLATIONAL ONCOLOGY

DOI: 10.1007/s12094-019-02145-4

IF: 2,737 Q: 3

Sastre J, de la Orden V, Martinez A, Bando I, Balbin M, Bellosillo B, Palanca S, Gomez MIP, Mediero B, Llovet P, Moral VM, Vieitez JM, Garcia-Alfonso P, Calle SG, Ortiz-Morales MJ, Salud A, Quintero G, Lopez C, Diaz-Rubio E, Aranda E

Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naive Metastatic Colorectal Cancer Patients Prospectively Collected

CLINICAL COLORECTAL CANCER

DOI: 10.1016/j.clcc.2020.02.014

IF: 3,245 Q: 3

Lorente D, Castro E, Lozano R, Puente J, Romero-Laorden N, Rodriguez-Vida A, Lainez N, Villatoro R, Llacer C, Cattrini C, Hernandez A, Domenech M, Zambrana F, Almagro E, Luque R, Martinez E, Lopez-Campos F, Gonzalez B, Mendez-Vidal MJ, Medina A, Piulats J

Association Between Second Progression-free Survival (PFS2) and Overall Survival in Metastatic Castration-resistant Prostate Cancer

EUROPEAN UROLOGY

DOI: 10.1016/j.eururo.2020.02.025

IF: 17,947 Q: 1 D: 1

Chibaudel B, Henriques J, Rakez M, Brenner B, Kim TW, Martinez-Villacampa M, Gallego-Plazas J, Cervantes A, Shim K, Jonker D, Guerin-Meyer V, Mineur L, Banzi C, Dewdney A, Dejthevaporn T, Bloemendal HJ, Roth A, Moehler M, Aranda E, Van Cutsem E, Tabernero J, Schmoll HJ, Hoff PM, Andre T, de Gramont A

Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer A Secondary Analysis of the AVANT Trial

JAMA NETWORK OPEN

DOI: 10.1001/jamanetworkopen.2020.20425

IF: 5,032 Q: 1

Garcia-Torres F, Jablonski MJ, Solis AG, Jaen-Moreno MJ, Galvez-Lara M, Moriana JA, Moreno-Diaz MJ, Aranda E

Caregiver Burden Domains and Their Relationship with Anxiety and Depression in the First Six Months of Cancer Diagnosis

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH

DOI: 10.3390/ijerph17114101

IF: 2,849 Q: 1

Toledano-Fonseca M, Cano MT, Inga E, Rodriguez-Alonso R, Gomez-Espana MA, Guil-Luna S, Mena-Osuna R, de la Haba-Rodriguez JR, Rodriguez-Ariza A, Aranda E

Circulating Cell-Free DNA-Based Liquid Biopsy Markers for the Non-Invasive Prognosis and Monitoring of Metastatic Pancreatic Cancer

CANCERS

DOI: 10.3390/cancers12071754

IF: 6,126 Q: 1

Fernandez-Montes A, Gravalos C, Pericay C, Safont MJ, Benavides M, EElez E, Garcia-Alfonso P, Garcia-Paredes B, Carrato A, Aranda E

Current Options for Third-line and Beyond Treatment of Metastatic Colorectal Cancer

Spanish TTD Group Expert Opinion

DOI: 10.1016/j.clcc.2020.04.003

IF: 3,245 Q: 3

Puente J, Anido U, Climent MA, Gonzalez-Billalabeitia E, Lainez N, Lambea J, Maroto JP, Mendez-Vidal MJ, Montesa A, Rodriguez A, Zambrana C, Gonzalez-del-Alba A

Expert recommendations on the management of patients with metastatic castration-resistant prostate cancer who progress after CHAARTED or LATITUDE

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

DOI: 10.1177/1758835920920067

IF: 6,852 Q: 1

Aranda E, Vieitez JM, Gomez-Espana A, Calle SG, Salud-Salvia A, Grana B, Garcia-Alfonso P, Rivera F, Quintero-Aldana GA, Reina-Zoilo JJ, Gonzalez-Flores E, Fernandez MS, Guillen-Ponce C, Garcia-Carbonero R, Safont MJ, Munoa AL, Garcia-Paredes B, Lopez RL, Sastre J, Diaz-Rubio E

FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and >= 3 circulating tumour cells: the randomised phase III VISNu-1 trial

ESMO OPEN

DOI: 10.1136/esmoopen-2020-000944

IF: 5,329 Q: 1

Perez-Ruiz E, Jimenez-Castro J, Berciano-Guerrero MA, Valdivia J, Estalella-Mendoza S, Toscano F, Artacho MRD, Garrido-Siles M, Martinez-Bautista MJ, Roldan RV, Rivas-Ruiz F, Nogales-Fernandez E, Morales C, Perez-Valderrama B, De la Cruz-Merino L, Rueda A

Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice

CLINICAL & TRANSLATIONAL ONCOLOGY

DOI: 10.1007/s12094-020-02315-9

IF: 2,737 Q: 3

Artigas L, Coma M, Matos-Filipe P, Aguirre-Plans J, Farres J, Valls R, Fernandez-Fuentes N, de la Haba-Rodriguez J, Olvera A, Barbera J, Morales R, Oliva B, Mas JM

In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm

PLOS ONE

DOI: 10.1371/journal.pone.0240149

IF: 2,74 Q: 2

Gonzalez-del-Alba A, Arranz JA, Bellmunt J, Maroto JP, Fernandez-Calvo O, Valderrama BP, Gonzalez-Billalabeitia E, Mendez-Vidal MJ, Cassinello J, Romero-Laorden N, Climent MA, Puentel J, Pelaez I, Lazaro-Quintela M, Gallardo E, Suarez C

Latest progress in molecular biology and treatment in genitourinary tumours

CLINICAL & TRANSLATIONAL ONCOLOGY

DOI: 10.1007/s12094-020-02373-z

IF: 2,737 Q: 3

Provencio M, Nadal E, Insa A, Garcia-Campelo MR, Casal-Rubio J, Domine M, Majem M, Rodriguez-Abreu D, Martinez-Marti A, Carpeno JD, Cobo M, Vivanco GL, Del Barco E, Caro RB, Vinolas N, Aranda IB, Viteri S, Pereira E, Royuela A, Casarrubios M, Anton CS, Parra ER, Wistuba I, Calvo V, Laza-Briviesca R, Romero A, Massuti B, Cruz-Bermudez A

Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial

LANCET ONCOLOGY

DOI: 10.1016/S1470-2045(20)30453-8

IF: 33,752 Q: 1 D: 1

Lopez-Sanchez LM, Aranda E, Rodriguez-Ariza A

Nitric oxide and tumor metabolic reprogramming

BIOCHEMICAL PHARMACOLOGY

DOI: 10.1016/j.bcp.2019.113769

IF: 4,96 Q: 1 D: 1

Viudez A, Carmona-Bayonas A, Gallego J, Lacalle A, Hernandez R, Cano JM, Macias I, Custodio A, de Castro EM, Sanchez A, Iglesia L, Reguera P, Visa L, Azkarate A, Sanchez-Canovas M, Mangas M, Limon ML, Martinez-Torron A, Asensio E, Ramchandani A, Martin-Carnicero, A (Martin-Carnicero, A

)[ 20 ] ; Hurtado, A (Hurtado, A

)[ 21 ] ; Cerda, P (Cerda, P

DOI: 10.1007/s12094-019-02183-y

IF: 2,737 Q: 3

Carrato A, Vieitez JM, Benavides M, Rodriguez-Garrote M, Castillo A, Ogalla GD, Bermejo LG, de Mena IR, Guillen-Ponce C, Aranda E

Phase I/II trial of sequential treatment of nab-paclitaxel in combination with gemcitabine followed by modified FOLFOX chemotherapy in patients with untreated metastatic exocrine pancreatic cancer: Phase I results

EUROPEAN JOURNAL OF CANCER

DOI: 10.1016/j.ejca.2020.07.035

IF: 7,275 Q: 1

Salazar R, Capdevila J, Manzano JL, Pericay C, Martinez-Villacampa M, Lopez C, Losa F, Safont MJ, Gomez-Espana A, Alonso-Orduna V, Escudero P, Gallego J, Garcia-Paredes B, Palacios A, Biondo S, Gravalos C, Aranda E

Phase II randomized trial of capecitabine with bevacizumab and external beam radiation therapy as preoperative treatment for patients with resectable locally advanced rectal adenocarcinoma: long term results

BMC CANCER

DOI: 10.1186/s12885-020-07661-z

IF: 3,15 Q: 3

Lluch A, Barrios CH, Torrecillas L, Ruiz-Borrego M, Bines J, Segalla J, Guerrero-Zotano A, Garcia-Saenz JA, Torres R, de la Haba J, Garcia-Martinez E, Gomez HL, Llombart A, Bofill JS, Baena-Canada JM, Barnadas A, Calvo L, Perez-Michel L, Ramos M, Fernande

Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)

JOURNAL OF CLINICAL ONCOLOGY

DOI: 10.1200/JCO.19.00904

IF: 32,956 Q: 1 D: 1

Lazaro M, Valderrama BP, Suarez C, de-Velasco G, Beato C, Chirivella I, Gonzalez-Del-Alba A, Lainez N, Mendez-Vidal MJ, Arranz JA

SEOM clinical guideline for treatment of kidney cancer (2019)

CLINICAL & TRANSLATIONAL ONCOLOGY

DOI: 10.1007/s12094-019-02285-7

IF: 2,737 Q: 3

Guillen-Ponce C, Lastra E, Lorenzo-Lorenzo I, Gomez TM, Chamorro RM, Sanchez-Heras AB, Serrano R, Rodriguez MCS, Soto JL, Robles L

SEOM clinical guideline on hereditary colorectal cancer (2019)

CLINICAL & TRANSLATIONAL ONCOLOGY

DOI: 10.1007/s12094-019-02272-y

IF: 2,737 Q: 3

Gallardo E, Medina J, Sanchez JC, Viudez A, Grande E, Porras I, Ramon y Cajal T, Trigo J, Iglesias L, Capdevila J

SEOM clinical guideline thyroid cancer (2019)

CLINICAL & TRANSLATIONAL ONCOLOGY

DOI: 10.1007/s12094-019-02284-8

IF: 2,737 Q: 3

Garcia-Torres F, Jablonski MJ, Solis AG, Moriana JA, Jaen-Moreno MJ, Moreno-Diaz MJ, Aranda E

Social support as predictor of anxiety and depression in cancer caregivers six months after cancer diagnosis: A longitudinal study

JOURNAL OF CLINICAL NURSING

DOI: 10.1111/jocn.15123

IF: 1,972 Q: 1

Rodriguez-Lescure A, de la Pena FA, Aranda E, Calvo A, Felip E, Garrido P, Vera R

Study of the Spanish Society of Medical Oncology (SEOM) on the access to oncology drugs and predictive biomarkers in Spain

CLINICAL & TRANSLATIONAL ONCOLOGY

DOI: 10.1007/s12094-020-02366-y

IF: 2,737 Q: 3

de las Heras BB, Cajal JCRY, Calvo EG, Rodriguez JD, Mata JG, Anton FM, Fernandez IP, Rodriguez-Lescure A, Sanchez CAR, Ruiz-Borrego M, Remak E, Barra M, Rivero M, Alvarez JS

The economic burden of metastatic breast cancer in Spain

EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE

DOI: 10.1136/ejhpharm-2017-001453

IF: 0,892 Q: 4

Aranda E, Polo E, Camps C, Carrato A, Diaz-Rubio E, Guillem V, Lopez R, Anton A

Treatment patterns for metastatic colorectal cancer in Spain

CLINICAL & TRANSLATIONAL ONCOLOGY

DOI: 10.1007/s12094-019-02279-5

IF: 2,737 Q: 3

Correa-Saez A, Jimenez-Izquierdo R, Garrido-Rodriguez M, Morrugares R, Munoz E, Calzado MA

Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): molecular basis, functions and role in diseases

CELLULAR AND MOLECULAR LIFE SCIENCES

DOI: 10.1007/s00018-020-03556-1

IF: 6,496 Q: 1

Fernandez-Bedmar Z, Anter J, Alonso-Moraga A, de la Torre PD, de Castro MDL, Millan-Ruiz Y, Sanchez-Frias M, Guil-Luna S

Red and White Wine Lees Show Inhibitory Effects on Liver Carcinogenesis

MOLECULAR NUTRITION & FOOD RESEARCH

DOI: 10.1002/mnfr.201800864

IF: 5,151 D: 1

Penarando J, Aranda E, Rodriguez-Ariza A

Immunomodulatory roles of nitric oxide in cancer: tumor microenvironment says "NO" to antitumor immune response

TRANSLATIONAL RESEARCH

DOI: 10.1016/j.trs1.2019.03.003

IF: 4,915 D: 1

Elez E, Pericay C, Valladares-Ayerbes M, Bando I, Safont MJ, Gallego J, Gravalos C, Arrivi A, Carrato A, Conde V, Ortiz MJ, Lopez C, Alonso B, de Mena IR, Diaz-Rubio E, Tabernero J, Aranda E

A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients

BRITISH JOURNAL OF CANCER

DOI: 10.1038/s41416-019-0537-z

IF: 5,416 Q: 1

Lopez-Sanchez LM, Jimenez-Izquierdo R, Penarando J, Mena R, Guil-Luna S, Toledano M, Conde F, Villar C, Diaz C, Ortea I, De la Haba-Rodriguez JR, Aranda E, Rodriguez-Ariza A

SWATH-based proteomics reveals processes associated with immune evasion and metastasis in poor prognosis colorectal tumours

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

DOI: 10.1111/jcmm.14693

IF: 4,658 Q: 1

Carrato A, Benavides M, Massuti B, Ferreiro-Monteagudo R, Alfonso PG, Falco E, Reboredo M, Cano T, Gallego J, Vieitez JM, Layos L, Salud A, Polo E, Dotor E, Duran-Ogalla G, Rodriguez-Garrote M, Calvo A, Grande E, Aranda E

First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

BMC CANCER

DOI: 10.1186/s12885-019-5753-7

IF: 2,933 Q: 3

Gomez-Espana MA, Gallego J, Gonzalez-Flores E, Maurel J, Paez D, Sastre J, Aparicio J, Benavides M, Feliu J, Vera R

SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018)

CLINICAL & TRANSLATIONAL ONCOLOGY

DOI: 10.1007/s12094-018-02002-w

IF: 2,441 Q: 3

Valverde A, Ciria R, Caballero-Villarraso J, Aguilar-Melero P, Ferrin G, Ranchal I, Linares C, Herencia C, Gonzalez-Rubio S, de la Mata M, Naranjo A, Briceno J

Bevacizumab Allows Preservation of Liver Function and its Regenerative Capacity after Major Hepatectomy

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY

DOI: 10.2174/1871520619666190417162409

IF: 2,18 Q: 3

Ciruelos E, Perez-Garcia JM, Gavila J, Rodriguez A, de la Haba-Rodriguez J

Maintenance Therapy in HER2-Negative Metastatic Breast Cancer: A New Approach for an Old Concept

CLINICAL DRUG INVESTIGATION

DOI: 10.1007/s40261-019-00790-9

IF: 1,918 Q: 3

Abad A, Martinez-Balibrea E, Vieitez JM, Alonso-Orduna V, Alfonso PG, Manzano JL, Massuti B, Benavides M, Carrato A, Zanui M, Gallego J, Gravalos C, Conde V, Provencio M, Valladares-Ayerbes M, Salazar R, Sastre J, Montagut C, Rivera F, Aranda E

Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial

ANNALS OF ONCOLOGY

IF: 13,926 Q: 1 D: 1

Penarando J, Lopez-Sanchez LM, Mena R, Guil-Luna S, Conde F, Hernandez V, Toledano M, Gudino V, Raponi M, Billard C, Villar C, Diaz C, Gomez-Barbadillo J, De la Haba-Rodriguez J, Myant K, Aranda E, Rodriguez-Ariza A

A role for endothelial nitric oxide synthase in intestinal stem cell proliferation and mesenchymal colorectal cancer

BMC BIOLOGY

IF: 5,77 Q: 1 D: 1

Aranda E, Garcia-Alfonso P, Benavides M, Ruiz AS, Guillen-Ponce C, Safont MJ, Alcaide J, Gomez A, Lopez R, Manzano JL, Urena MM, Sastre J, Rivera F, Gravalos C, Garcia T, Martin-Valades JI, Falco E, Navalon M, Flores EG, Tapiador AMG, Munoz AML, Barrajon E, Reboredo M, Teijido PG, Viudez A, Cardenas N, Diaz-Rubio E

First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study

EUROPEAN JOURNAL OF CANCER

IF: 7,191 Q: 1

Garcia-Alfonso P, Benavides M, Falco E, Munoz A, Gomez A, Sastre J, Rivera F, Montagut C, Salgado M, Lopez-Ladron A, Lopez R, de Mena IR, Duran G, Aranda E

Single-Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial)

ONCOLOGIST

IF: 5,306 Q: 1

Alsina M, Rivera F, Ramos FJ, Galan M, Lopez R, Garcia-Alfonso P, Ales-Martinez JE, Queralt B, Anton A, Carrato A, Gravalos C, Mendez-Vidal MJ, Lopez C, de Mena IR, Tabernero J, Giralt J, Aranda E

A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients

TARGETED ONCOLOGY

IF: 3,877 Q: 2

De La Rochere P, Guil-Luna S, Decaudin D, Azar G, Sidhu SS, Piaggio E

Humanized Mice for the Study of Immuno-Oncology

TRENDS IN IMMUNOLOGY

IF: 14,188 Q: 1 D: 1

Gravalos C, Carrato A, Tobena M, Rodriguez-Garrote M, Soler G, Vieitez JM, Robles L, Valladares-Ayerbes M, Polo E, Limon ML, Safont MJ, de Castro EM, Garcia-Alfonso P, Aranda E

A Randomized Phase II Study of Axitinib as Maintenance Therapy After First-line Treatment for Metastatic Colorectal Cancer

CLINICAL COLORECTAL CANCER

IF: 3,861 Q: 2

Munoz AP, Garcia JMC, Rubio MDT, Vicente AMG, Pardo FJP, Londono GAJ, Castrejon AS, Aguilar EA

Value of [F-18]FDG-PET/CT and CA125, serum levels and kinetic parameters, in early detection of ovarian cancer recurrence: Influence of histological subtypes and tumor stages

MEDICINE; 2018:97(17):Núm artículo e0098

IF: 2,028 Q: 2

Mendez-Vidal MJ, Molina A, Anido U, Chirivella I, Etxaniz O, Fernandez-Parra E, Guix M, Hernandez C, Lambea J, Montesa A, Pinto A, Ros S, Gallardo E

Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma

BMC PHARMACOLOGY & TOXICOLOGY

IF: 1,865 Q: 3

Munoz AP, Garcia JMC, Rubio PT, Vicente AMG, Garcia BG, Guardia MEB, Castrejon AS, Aguilard EA

Usefulness of CA125 and its kinetic parameters and positron emission tomography/computed tomography (PET/CT) with fluorodeoxyglucose [F-18] FDG) in the detection of recurrent ovarian cancer

MEDICINA CLINICA

IF: 1,168 Q: 3

Lopez RL, Herrero CC, Khosravi-Shahi P, Porta VG, Mena AC, Garcia-Foncillas J, Hernandez JJC, Vilaplana PG, Torres AA, Diaz-Rubio E, Saus MF, Aguilar EA

Oncologist's knowledge and implementation of guidelines for breakthrough cancer pain in Spain: CONOCE study

CLINICAL & TRANSLATIONAL ONCOLOGY

IF: 2,392 Q: 3

Rimawi M, Ferrero JM, de la Haba-Rodriguez J, Poole C, De Placido S, Osborne CK, Hegg R, Easton V, Wohlfarth C, Arpino G

First-Line Trastuzumab Plus an Aromatase Inhibitor, With or Without Pertuzumab, in Human Epidermal Growth Factor Receptor 2-Positive and Hormone Receptor-Positive Metastatic or Locally Advanced Breast Cancer (PERTAIN): A Randomized, Open-Label Phase II Trial

JOURNAL OF CLINICAL ONCOLOGY

IF: 26,303 Q: 1 D: 1

Sjoquist KM, Renfro LA, Simes RJ, Tebbutt NC, Clarke S, Seymour MT, Adams R, Maughan TS, Saltz L, Goldberg RM, Schmoll HJ, Van Cutsem E, Douillard JY, Hoff PM, Hecht JR, Tournigand C, Punt CJA, Koopman M, Hurwitz H, Heinemann V, Zalcberg JR

Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

IF: 11,238 Q: 1 D: 1

Salem ME, Yin J, Weinberg BA, Renfro LA, Pederson LD, Maughan TS, Adams RA, Van Cutsem E, Falcone A, Tebbutt NC, Seymour MT, Diaz-Rubio E, Aranda E, Bokemeyer C, Heinemann V, Wasan H, de Gramont A, Grothey A, Shi Q, Sargent DJ, Marshall JL

Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database

EUROPEAN JOURNAL OF CANCER

IF: 7,191 Q: 1

van Rooijen KL, Shi Q, Goey KKH, Meyers J, Heinemann V, Diaz-Rubio E, Aranda E, Falcone A, Green E, de Gramont A, Sargent DJ, Punt CJA, Koopman M

Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database

EUROPEAN JOURNAL OF CANCER

IF: 7,191 Q: 1

Garcia-Foncillas J, Tabernero J, Elez E, Aranda E, Benavides M, Camps C, Jantus-Lewintre E, Lopez R, Muinelo-Romay L, Montagut C, Anton A, Lopez G, Diaz-Rubio E, Rojo F, Vivancos A

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer

BRITISH JOURNAL OF CANCER

IF: 5,922 Q: 1

Irigoyen A, Jimenez-Luna C, Benavides M, Caba O, Gallego J, Ortuno FM, Guillen-Ponce C, Rojas I, Arande E, Torres C, Prados J

Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers

PLOS ONE

IF: 2,766 Q: 1

Arriola E, Gomez RG, Diz P, Majem M, Aguillo MM, Valdivia J, Paredes A, Sanchez-Torres JM, Munoz SP, Barneto I, Gutierrez V, Santiago JMA, Aparisi F, Isla D, Ponce S, Baz DV, Artal A, Amador M, Provencio M

Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain

BMC CANCER 2018; 18:Núm artículo 106

IF: 3,288 Q: 2

Arjona-Sanchez A, Barrios P, Boldo-Roda E, Camps B, Carrasco-Campos J, Martin VC, Garcia-Fadrique A, Gutierrez-Calvo A, Morales R, Ortega-Perez G, Perez-Viejo E, Prada-Villaverde A, Torres-Melero J, Vicente E, Villarejo-Campos P, Sanchez-Hidalgo JM, Casado-Adam A, Garcia-Martin R, Medina M, Caro T, Villar C, Aranda E, Cano-Osuna MT, Diaz-Lopez C, Torres-Tordera E, Briceno-Delgado FJ, Rufian-Pena S

HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma

BMC CANCER

IF: 3,288 Q: 2

Castellano D, Maroto JP, Espinosa E, Grande E, Bolos MV, Llinares J, Esteban E, del Alba AG, Climent MA, Arranz JA, Mendez MJ, Parra EF, Anton-Aparicio L, Bayona C, Gallegos I, Gallardo E, Samaniego L, Donas JG

Experience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studies

EXPERT OPINION ON DRUG SAFETY

IF: 3,156 Q: 2

Caries J, Castellano D, Mendez-Vidal MJ, Mellado B, Saez MI, del Alba AG, Perez-Gracia JL, Jimenez J, Suarez C, Sepulveda JM, Manneh R, Porras I, Lopez C, Morales-Barrera R, Arranz JA

Circulating Tumor Cells as a Biomarker of Survival and Response to Radium-223 Therapy: Experience in a Cohort of Patients With Metastatic Castration-Resistant Prostate Cancer

CLINICAL GENITOURINARY CANCER

IF: 2,539 Q: 2

Minig L, Cabrera S, Oliver R, Couso A, Rubio MJ, Iacoponi S, Martin-Salamanca MB, Carballo-Rastrilla S, Cadenas-Rebollo JM, Garcia-Garcia A, Gil-Ibanez B, Juan-Fita MJ, Patrono MG

Pathology findings and clinical outcomes after risk reduction salpingo-oophorectomy in BRCA mutation carriers: a multicenter Spanish study

CLINICAL & TRANSLATIONAL ONCOLOGY

IF: 2,392 Q: 3

Gallardo E, Mendez-Vidal MJ, Perez-Gracia JL, Sepulveda-Sanchez JM, Campayo M, Chirivella-Gonzalez I, Garcia-del-Muro X, Gonzalez-Del-Alba A, Grande E, Suarez C

SEOM clinical guideline for treatment of kidney cancer (2017)

CLINICAL & TRANSLATIONAL ONCOLOGY

IF: 2,392 Q: 3

Carles J, Mendez MJ, Pinto A, Saez MI, Arranz JA, Maroto P, Lopez-Criado P, Mellado B, Donas JG, Hernando S, Leon L, del Alba AG, Lainez N, Esteban E, Reynes G, Perez-Gracia JL, Germa JR, Lopez-Brea M, Perez-Valderrama B, Moretones C, Castellano D

Radium-223 international early access program: results from the Spanish subset

FUTURE ONCOLOGY

IF: 2,369 Q: 3

Garcia-Borruel MM, Molina AJH, Peralvarez MLR, Rincon EM, Medrano IP, Ruiz FJS, Juanena LLC, Navarro MP, Rodriguez AN, Pastor CV

Post-colonoscopy colorectal cancer: Characteristics and predictive factors

MEDICINA CLINICA

IF: 1,168 Q: 3